Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ÿnsect is a French agri-food and environmental biotechnology company focused on farming mealworms at industrial scale to produce premium ingredients for animal nutrition, pet food, human food, and plant nutrition. The company operates vertically integrated insect production systems that combine robotics, computer vision, artificial intelligence, and genetics to optimize breeding and processing. Its product portfolio includes insect proteins, oils, and frass-based fertilizers, and it has positioned itself as a sustainable alternative to conventional feed and food ingredients. Founded in 2011, Ÿnsect has built a large patent estate and expanded through acquisitions such as Protifarm and Jord. Although the company entered court-supervised restructuring in 2025, it has continued operating and presenting itself as an active commercial business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ÿnsect.